New genetic drivers in hemorrhagic hereditary telangiectasia
Eur J Intern Med. 2023 Sep 7:S0953-6205(23)00308-4. doi: 10.1016/j.ejim.2023.08.024.…
Impact of SCHOLAR-1 Criteria on Chimeric Antigen Receptor T Cell Therapy Efficacy in Aggressive B Lymphoma: A Real-World GELTAMO/GETH Study
Transplant Cell Ther. 2023 Sep 1:S2666-6367(23)01508-7. doi:…
Clinical practice guidelines for the diagnosis and surveillance of BAP1 tumour predisposition syndrome
Eur J Hum Genet. 2023 Nov;31(11):1261-1269. doi: 10.1038/s41431-023-01448-z.…
EUSICA/COST IMMUNO-model workshop fostering collaboration to advance sinonasal cancer research: A meeting report
Oral Oncol. 2023 Nov;146:106543. doi: 10.1016/j.oraloncology.2023.106543.…
Prognostic Role of Neutrophil, Monocyte and Platelet to Lymphocyte Ratios in Advanced Ovarian Cancer According to the Time of Debulking Surgery
Int J Mol Sci. 2023 Jul 13;24(14):11420. doi: 10.3390/ijms241411420.ABSTRACTDespite…
Lenalidomide and dexamethasone maintenance with or without ixazomib, tailored by residual disease status in myeloma
Blood. 2023 Nov 2;142(18):1518-1528. doi: 10.1182/blood.2022019531.ABSTRACTFrom…
Immunostimulatory gene therapy targeting CD40, 4-1BB and IL-2R activates DCs and stimulates antigen-specific T-cell and NK-cell responses in melanoma models
J Transl Med. 2023 Jul 27;21(1):506. doi: 10.1186/s12967-023-04374-2.ABSTRACTBACKGROUND:…
Quantifying the available capacity and resource needs for provision of CAR-T therapies in the National Health Service in Spain: a survey-based study
BMJ Open. 2023 Jul 25;13(7):e071371. doi: 10.1136/bmjopen-2022-071371.ABSTRACTOBJECTIVES:…
SWI/SNF Complex Alterations in Tumors with Rhabdoid Features: Novel Therapeutic Approaches and Opportunities for Adoptive Cell Therapy
Int J Mol Sci. 2023 Jul 6;24(13):11143. doi: 10.3390/ijms241311143.ABSTRACTThe…
γ-Secretase inhibitors plus anti-BCMA chimeric antigen receptor T cells
Lancet Oncol. 2023 Jul;24(7):715-717. doi: 10.1016/S1470-2045(23)00283-8.NO…
MBD4-associated neoplasia syndrome: screening of cases with suggestive phenotypes
Eur J Hum Genet. 2023 Oct;31(10):1185-1189. doi: 10.1038/s41431-023-01418-5.…
Addendum: Immune-related adverse events and atypical radiological response with checkpoint inhibitor immunotherapy in an elderly patient with high PD-L1 expressing lung adenocarcinoma
Oncotarget. 2023 Jul 1;14:668. doi: 10.18632/oncotarget.28471.NO…
